Our study is the first to show that in the case of an influenza pandemic, while prophylactic oseltamivir treatment may limit virus growth and reduce disease severity, the capacity to generate memory CD8+ T cells specific for the newly emerged virus is not compromised. The gene discussed is CD8A; the disease is influenza.